世界のRNAベースの治療薬とワクチン市場：市場規模・現状・予測

• 英文タイトル：Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7978
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、RNAベースの治療薬とワクチンのグローバル市場について調査・分析したレポートで、種類別（RNAベースの治療薬、RNAベースのワクチン）、用途別（腫瘍学、免疫学、眼科、心血管疾患、感染症、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・RNAベースの治療薬とワクチンの世界市場規模
・主要企業別市場シェア
・RNAベースの治療薬とワクチンの世界市場規模：種類別（RNAベースの治療薬、RNAベースのワクチン）
・RNAベースの治療薬とワクチンの世界市場規模：用途別（腫瘍学、免疫学、眼科、心血管疾患、感染症、その他）
・RNAベースの治療薬とワクチンのアメリカ市場規模（種類別、用途別）
・RNAベースの治療薬とワクチンのヨーロッパ市場規模（種類別、用途別）
・RNAベースの治療薬とワクチンの中国市場規模（種類別、用途別）
・RNAベースの治療薬とワクチンの日本市場規模（種類別、用途別）
・RNAベースの治療薬とワクチンの東南アジア市場規模（種類別、用途別）
・RNAベースの治療薬とワクチンのインド市場規模（種類別、用途別）
・RNAベースの治療薬とワクチンの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・RNAベースの治療薬とワクチンの世界市場予測（2019年-2025年）
・RNAベースの治療薬とワクチンの地域別市場予測（2019年-2025年）
...

RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
In 2018, the global RNA-Based Therapeutics and Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global RNA-Based Therapeutics and Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNA-Based Therapeutics and Vaccines development in United States, Europe and China.

The key players covered in this study
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis

Market segment by Type, the product can be split into
RNA-Based Therapeutics
RNA-Based Vaccines

Market segment by Application, split into
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global RNA-Based Therapeutics and Vaccines status, future forecast, growth opportunity, key market and key players.
To present the RNA-Based Therapeutics and Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of RNA-Based Therapeutics and Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 RNA-Based Therapeutics
1.4.3 RNA-Based Vaccines
1.5 Market by Application
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Immunology
1.5.4 Ophthalmology
1.5.5 Cardiovascular Diseases
1.5.6 Infectious Diseases
1.5.7 Genetic Diseases
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 RNA-Based Therapeutics and Vaccines Market Size
2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Regions
2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2014-2025)
2.2.2 RNA-Based Therapeutics and Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 RNA-Based Therapeutics and Vaccines Market Size by Manufacturers
3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.3 Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service
3.4 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019)
4.2 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
5.2 RNA-Based Therapeutics and Vaccines Key Players in United States
5.3 United States RNA-Based Therapeutics and Vaccines Market Size by Type
5.4 United States RNA-Based Therapeutics and Vaccines Market Size by Application

6 Europe
6.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
6.2 RNA-Based Therapeutics and Vaccines Key Players in Europe
6.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type
6.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application

7 China
7.1 China RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
7.2 RNA-Based Therapeutics and Vaccines Key Players in China
7.3 China RNA-Based Therapeutics and Vaccines Market Size by Type
7.4 China RNA-Based Therapeutics and Vaccines Market Size by Application

8 Japan
8.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
8.2 RNA-Based Therapeutics and Vaccines Key Players in Japan
8.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type
8.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
9.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia
9.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type
9.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application

10 India
10.1 India RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
10.2 RNA-Based Therapeutics and Vaccines Key Players in India
10.3 India RNA-Based Therapeutics and Vaccines Market Size by Type
10.4 India RNA-Based Therapeutics and Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2014-2019)
11.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America
11.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type
11.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application

12 International Players Profiles
12.1 Alnylam Pharmaceuticals
12.1.1 Alnylam Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 RNA-Based Therapeutics and Vaccines Introduction
12.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.1.5 Alnylam Pharmaceuticals Recent Development
12.2 Arbutus Biopharma
12.2.1 Arbutus Biopharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 RNA-Based Therapeutics and Vaccines Introduction
12.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.2.5 Arbutus Biopharma Recent Development
12.3 Arrowhead Pharmaceuticals
12.3.1 Arrowhead Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 RNA-Based Therapeutics and Vaccines Introduction
12.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.3.5 Arrowhead Pharmaceuticals Recent Development
12.4 BioNTech
12.4.1 BioNTech Company Details
12.4.2 Company Description and Business Overview
12.4.3 RNA-Based Therapeutics and Vaccines Introduction
12.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.4.5 BioNTech Recent Development
12.5 CureVac
12.5.1 CureVac Company Details
12.5.2 Company Description and Business Overview
12.5.3 RNA-Based Therapeutics and Vaccines Introduction
12.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.5.5 CureVac Recent Development
12.6 Dicerna Pharmaceuticals
12.6.1 Dicerna Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 RNA-Based Therapeutics and Vaccines Introduction
12.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.6.5 Dicerna Pharmaceuticals Recent Development
12.7 Regulus Therapeutics
12.7.1 Regulus Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 RNA-Based Therapeutics and Vaccines Introduction
12.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.7.5 Regulus Therapeutics Recent Development
12.8 Marina Biotech
12.8.1 Marina Biotech Company Details
12.8.2 Company Description and Business Overview
12.8.3 RNA-Based Therapeutics and Vaccines Introduction
12.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.8.5 Marina Biotech Recent Development
12.9 MiRagen Therapeutics
12.9.1 MiRagen Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 RNA-Based Therapeutics and Vaccines Introduction
12.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.9.5 MiRagen Therapeutics Recent Development
12.10 Moderna Therapeutics
12.10.1 Moderna Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 RNA-Based Therapeutics and Vaccines Introduction
12.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)
12.10.5 Moderna Therapeutics Recent Development
12.11 Quark Pharmaceuticals
12.12 Roche
12.13 Sylentis

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table RNA-Based Therapeutics and Vaccines Key Market Segments
Table Key Players RNA-Based Therapeutics and Vaccines Covered
Table Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type 2014-2025
Figure RNA-Based Therapeutics Figures
Table Key Players of RNA-Based Therapeutics
Figure RNA-Based Vaccines Figures
Table Key Players of RNA-Based Vaccines
Table Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application 2014-2025 (Million US$)
Figure Oncology Case Studies
Figure Immunology Case Studies
Figure Ophthalmology Case Studies
Figure Cardiovascular Diseases Case Studies
Figure Infectious Diseases Case Studies
Figure Genetic Diseases Case Studies
Figure Others Case Studies
Figure RNA-Based Therapeutics and Vaccines Report Years Considered
Table Global RNA-Based Therapeutics and Vaccines Market Size 2014-2025 (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2014-2025 (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2014-2019 (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2014-2019
Figure Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2014-2019
Figure Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2019
Table Market Top Trends
Table Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2014-2019) (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Share by Manufacturers (2014-2019)
Figure Global RNA-Based Therapeutics and Vaccines Market Share by Manufacturers in 2018
Table Global RNA-Based Therapeutics and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service
Table Date of Enter into RNA-Based Therapeutics and Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size Share by Type (2014-2019)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2014-2019)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size Share by Application (2014-2019)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2014-2019)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application in 2018
Figure United States RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table United States Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table United States Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table United States RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table United States RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table United States RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table United States RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table Europe Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table Europe Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table Europe RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table Europe RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Figure China RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table China Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table China Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table China RNA-Based Therapeutics and Vaccines Market Size by Type (2014-20189) (Million US$)
Table China RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table China RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table China RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Figure Japan RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table Japan Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table Japan Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table Japan RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table Japan RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Figure India RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table India Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table India Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table India RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table India RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table India RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table India RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Figure Central & South America RNA-Based Therapeutics and Vaccines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players RNA-Based Therapeutics and Vaccines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players RNA-Based Therapeutics and Vaccines Market Share (2018-2019)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2014-2019) (Million US$)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Share by Type (2014-2019)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2014-2019) (Million US$)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Share by Application (2014-2019)
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019) (Million US$)
Figure Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Alnylam Pharmaceuticals Recent Development
Table Arbutus Biopharma Company Details
Table Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Arbutus Biopharma Recent Development
Table Arrowhead Pharmaceuticals Company Details
Table Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Arrowhead Pharmaceuticals Recent Development
Table BioNTech Company Details
Table BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table BioNTech Recent Development
Table CureVac Company Details
Table CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table CureVac Recent Development
Table Dicerna Pharmaceuticals Company Details
Table Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Dicerna Pharmaceuticals Recent Development
Table Regulus Therapeutics Company Details
Table Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Regulus Therapeutics Recent Development
Table Marina Biotech Company Details
Table Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Marina Biotech Recent Development
Table MiRagen Therapeutics Company Details
Table MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table MiRagen Therapeutics Recent Development
Table Moderna Therapeutics Company Details
Table Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2014-2019)(Million US$)
Figure Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2014-2019)
Table Moderna Therapeutics Recent Development
Table Quark Pharmaceuticals Company Details
Table Roche Company Details
Table Sylentis Company Details
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions (Million US$) 2019-2025
Figure Global RNA-Based Therapeutics and Vaccines Market Size Share by Regions (2019-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Share by Regions in 2025
Figure United States RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure China RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Japan RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure India RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America RNA-Based Therapeutics and Vaccines Market Size Forecast (2019-2025)(Million USD)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Product (2019-2025) (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Product (2019-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Product in 2025
Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2025) (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の樹状細胞がんワクチン市場：市場規模・現状・予測

Global Dendritic Cell Cancer Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7076 2019年6月14日 108Pages
当資料は、樹状細胞がんワクチンのグローバル市場について調査・分析したレポートで、種類別（CreaVax、Sipuleucel-T（プロバンジ）、その他）、用途別（小児、大人）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界のペプチドベースの胃腸障害治療薬市場：市場規模・現状・予測

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7787 2019年6月14日 96Pages
当資料は、ペプチドベースの胃腸障害治療薬のグローバル市場について調査・分析したレポートで、種類別（テドグルタイド、リナクロチド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界のペプチドベースのがん治療薬市場：市場規模・現状・予測

Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7786 2019年6月14日 93Pages
当資料は、ペプチドベースのがん治療薬のグローバル市場について調査・分析したレポートで、種類別（ゴセレリン、ボルテゾミブ、ロイプロレリン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報...

世界の核酸ベースの治療薬市場：市場規模・現状・予測

Global Nucleic Acid-based Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7692 2019年6月14日 96Pages
当資料は、核酸ベースの治療薬のグローバル市場について調査・分析したレポートで、種類別（アンチセンスおよびアンチ遺伝子、短い阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、その他）、用途別（単遺伝性疾患、多重遺伝性疾患）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南...

世界の予防用ヒトワクチン市場：市場規模・現状・予測

Global Prophylactic Human Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7890 2019年6月14日 107Pages
当資料は、予防用ヒトワクチンのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（小児予防ワクチン、成人予防ワクチン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界のペプチドベースの代謝障害治療薬市場：市場規模・現状・予測

Global Peptide Based Metabolic Disorders Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7788 2019年6月14日 98Pages
当資料は、ペプチドベースの代謝障害治療薬のグローバル市場について調査・分析したレポートで、種類別（エクセナチド、リラグルチド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...

世界のワクチンと予防接種市場：市場規模・現状・予測

Global Vaccines & Vaccination Market Size, Status and Forecast 2019-2025
QYR9N8164 2019年6月14日 99Pages
当資料は、ワクチンと予防接種のグローバル市場について調査・分析したレポートで、種類別（サブユニットワクチン、弱毒化生ワクチン、コンジュゲートワクチン、不活化ワクチン、組換えベクターワクチン、その他）、用途別（小児科疾患市場、世界の成人病）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イ...

世界の予防的B型肝炎ウイルスワクチン市場：市場規模・現状・予測

Global Prophylactic Hepatitis B Virus Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7889 2019年6月14日 93Pages
当資料は、予防的B型肝炎ウイルスワクチンのグローバル市場について調査・分析したレポートで、種類別（B型肝炎、肝硬変、肝細胞がん、肝不全）、用途別（病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の酒さ治療薬市場：市場規模・現状・予測

Global Rosacea Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7983 2019年6月14日 93Pages
当資料は、酒さ治療薬のグローバル市場について調査・分析したレポートで、種類別（抗菌剤、アルファアゴニスト、レチノイド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界の睡眠障害治療薬市場：市場規模・現状・予測

Global Sleep Disorder Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8054 2019年6月14日 96Pages
当資料は、睡眠障害治療薬のグローバル市場について調査・分析したレポートで、種類別（不眠症、過度の睡眠、睡眠障害）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のペプチドベースの胃腸障害治療薬市場：市場規模・現状・予測 Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.In 2018, the global Peptide Based Gastrointestinal Disorders Ther…
世界のペプチドベースのがん治療薬市場：市場規模・現状・予測 Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was…
世界の核酸ベースの治療薬市場：市場規模・現状・予測 Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of…
世界のペプチドベースの代謝障害治療薬市場：市場規模・現状・予測 A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…
世界の樹状細胞がんワクチン市場：市場規模・現状・予測 Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine…